BCRX
BioCryst Pharmaceuticals, Inc. · Healthcare
Chief Commercial Officer Charles K Gayer sold $66K of BioCryst Pharmaceuticals, Inc.
Sold$66,490
$10.90Price
6,100Shares
−3%Stake
What BCRX did after the filing
- The stock from Mon, Dec 19 close, $10.63
- +1.0%
- S&P 500, same days
- +9.7%
Measured over 30 trading days, to the Feb 2 close.
Traded Thu, Dec 15. Filed Mon, Dec 19, 11:48 AM ET, during the session. Returns use the Dec 19 close and the Feb 2 close. Not investment advice.